VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $31,169 | -99.4% | 1,035,192 | +404.1% | 2.95% | +259.0% |
| Q3 2022 | $4,953,000 | -83.4% | 205,368 | -81.1% | 0.82% | -81.9% |
| Q2 2022 | $29,775,000 | +66.4% | 1,087,482 | +133.1% | 4.54% | +134.7% |
| Q1 2022 | $17,892,000 | +19.9% | 466,554 | -7.9% | 1.93% | +43.1% |
| Q3 2021 | $14,926,000 | -51.3% | 506,491 | -51.6% | 1.35% | +45.9% |
| Q4 2019 | $30,658,000 | +1.0% | 1,047,074 | -11.8% | 0.93% | -21.4% |
| Q2 2019 | $30,359,000 | +1159.2% | 1,187,759 | +998.8% | 1.18% | +2256.0% |
| Q2 2018 | $2,411,000 | -96.5% | 108,100 | -96.3% | 0.05% | -95.0% |
| Q4 2017 | $68,495,000 | +71.4% | 2,947,300 | +69.3% | 1.01% | +121.3% |
| Q3 2017 | $39,966,000 | -67.8% | 1,740,700 | -70.7% | 0.46% | -85.4% |
| Q4 2016 | $124,302,000 | +76.1% | 5,941,800 | +122.4% | 3.13% | +34.2% |
| Q3 2016 | $70,602,000 | – | 2,671,300 | – | 2.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |